$0.53 -0.02 (%) Cytori Therapeutics Inc - NASDAQ

Jul. 6, 2015 | 04:00 PM

Partner Headlines

  1. Wall Street's Best and Worst Calls of the First Quarter 2015

    GuruFocus | May. 7, 2015 | 16:03PM EST
  2. Morning Market Gainers

    Benzinga | Feb. 27, 2015 | 09:44AM EST
  3. Cytori Receives Positive European Opinion on Orphan Drug Status

    Benzinga | Feb. 24, 2015 | 08:06AM EST
  4. Morning Market Gainers

    Benzinga | Jan. 12, 2015 | 09:42AM EST
  5. Cytori Therapeutics, Inc. To Raise $13.5M In Registered Direct Offering

    Benzinga | Oct. 8, 2014 | 08:01AM EST
  6. Cytori Reports Consolidation, Restructuring of Operations

    Benzinga | Sep. 22, 2014 | 08:05AM EST
  7. Stocks Hitting 52-Week Lows

    Benzinga | Aug. 22, 2014 | 10:36AM EST
  8. Ascendiant Downgrades Cytori Therapeutics As ATHENA Trials Are Put On Hold

    Benzinga | Aug. 6, 2014 | 11:31AM EST
  9. Stocks Hitting 52-Week Lows

    Benzinga | Aug. 6, 2014 | 10:26AM EST
  10. Morning Market Losers

    Benzinga | Aug. 6, 2014 | 10:00AM EST
  11. Benzinga's Top Downgrades

    Benzinga | Aug. 6, 2014 | 09:13AM EST
  12. Ascendiant Capital Downgrades Cytori Therapeutics To Hold

    Benzinga | Aug. 6, 2014 | 07:41AM EST
  13. UPDATE: Cytori Says It has Placed Enrollment in Athena On Hold and Puts Athena II Trials On Clinical Hold

    Benzinga | Aug. 5, 2014 | 16:07PM EST
  14. Morning Market Movers

    Benzinga | Jul. 7, 2014 | 09:37AM EST
  15. Cytori Announces Senior Management Changes; Christopher Calhoun CEO and Director of Cytori Therapeutics, is Retiring as CEO of the Company, Effective Immediately

    Benzinga | Apr. 2, 2014 | 16:07PM EST
  16. Cytori Receives IDE Approval from FDA to Initiate US Clinical Trial of Adipose-Derived Regenerative Cells in Hamstring Injuries

    Benzinga | Jan. 13, 2014 | 08:29AM EST
  17. Cytori Receives $12M First Installment from Lorem Vascular Partnership Equity Agreement

    Benzinga | Nov. 7, 2013 | 12:43PM EST
  18. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 5, 2013 | 08:11AM EST
  19. Benzinga's Top Pre-Market Gainers

    Benzinga | Sep. 10, 2013 | 08:09AM EST
  20. Cytori's Celution® System Approved in Australia for Processing and Delivering Adipose-Derived Regenerative Cells

    Benzinga | Aug. 7, 2013 | 08:07AM EST
  21. Morning Market Losers

    Benzinga | Dec. 14, 2012 | 03:04AM EST
  22. Cytori Awarded Contract Valued up to $106 Million by Biomedical Advanced Research and Development Authority

    Benzinga | Sep. 28, 2012 | 01:32AM EST
  23. Cytori Therapeutics Inc Reports Operating Results (10-Q)

    GuruFocus | Aug. 9, 2012 | 12:29PM EST
  24. Cytori Provides Strategic Outlook, Near Term Objectives

    Benzinga | Mar. 8, 2012 | 09:13AM EST
  25. Notable Put Options Activity in Cytori Therapeutics

    Benzinga | Mar. 5, 2012 | 06:00AM EST
  26. Cytori Therapeutics Inc (CYTX) CEO Christopher J Calhoun sells 205,000 Shares

    GuruFocus | Feb. 6, 2012 | 10:50AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!